Cargando…
Modulation of Aβ(42 )low-n oligomerization using a novel yeast reporter system
BACKGROUND: While traditional models of Alzheimer's disease focused on large fibrillar deposits of the Aβ(42 )amyloid peptide in the brain, recent work suggests that the major pathogenic effects may be attributed to SDS-stable oligomers of Aβ(42). These Aβ(42 )oligomers represent a rational tar...
Autores principales: | Bagriantsev, Sviatoslav, Liebman, Susan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1594584/ https://www.ncbi.nlm.nih.gov/pubmed/17002801 http://dx.doi.org/10.1186/1741-7007-4-32 |
Ejemplares similares
-
Inhibition of Aβ(42) oligomerization in yeast by a PICALM
ortholog and certain FDA approved drugs
por: Park, Sei-Kyoung, et al.
Publicado: (2016) -
Development and validation of a yeast high-throughput screen for inhibitors of Aβ(42) oligomerization
por: Park, Sei-Kyoung, et al.
Publicado: (2011) -
Endocytic pathways mediating oligomeric Aβ42 neurotoxicity
por: Yu, Chunjiang, et al.
Publicado: (2010) -
A common pathway for detergent-assisted oligomerization of Aβ42
por: Muhammedkutty, Fidha Nazreen Kunnath, et al.
Publicado: (2023) -
Conformational Essentials Responsible for Neurotoxicity of Aβ42 Aggregates Revealed by Antibodies against Oligomeric Aβ42
por: Song, Chuli, et al.
Publicado: (2022)